The investigational proteasome inhibitor ixazomib for the treatment of multiple myeloma.

The investigational proteasome inhibitor ixazomib for the treatment of multiple myeloma.

Item
http://www.wikidata.org/entity/Q38400460
Oral proteasome inhibitor with strong preclinical efficacy in myeloma models.Pharmacokinetics of ixazomib, an oral proteasome inhibitor, in solid tumour patients with moderate or severe hepatic impairmentMultiple myeloma: patient outcomes in real-world practice.Dose and Schedule Selection of the Oral Proteasome Inhibitor Ixazomib in Relapsed/Refractory Multiple Myeloma: Clinical and Model-Based Analyses.Vision Statement for Multiple Myeloma: Future Directions.Multiple myeloma: practice patterns across Europe.The magnitude of neurotoxicity in patients with multiple myeloma and the impact of dose modifications: results from the population-based PROFILES registry.Reviving the guardian of the genome: Small molecule activators of p53.Survival of non-transplant patients with multiple myeloma in routine care differs from that in clinical trials-data from the prospective German Tumour Registry Lymphatic Neoplasms
P2860

The investigational proteasome inhibitor ixazomib for the treatment of multiple myeloma.

Item
http://www.wikidata.org/entity/Q38400460
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
The investigational proteasome inhibitor ixazomib for the treatment of multiple myeloma.
@en
type
label
The investigational proteasome inhibitor ixazomib for the treatment of multiple myeloma.
@en
prefLabel
The investigational proteasome inhibitor ixazomib for the treatment of multiple myeloma.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
The investigational proteasome inhibitor ixazomib for the treatment of multiple myeloma
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921